The phenomenon of aging is most common to all living organisms and its definition is the loss or reduction of the ability to reproduce offspring and the slowly decrease in physical fitness. The current aging population is considered to be a major burden of the 21st century. Therefore, in order to slow the process of aging and maintain the health of the elderly, the discovery of new antiaging medicine remains a top priority. Several well-known researchers are working on this issue which is considered to be a multi-billions of dollars industry in future. Institutes like CRG with scientists like Nicholas Stroustrup and David Sinclair and many others have discovered some advancement in this regard, and looking forward for many more to come, some of these advancements are being described below. The aging process makes death increasingly possible, but it has a stochastic aspect that produces a wide distribution of life span even in homogeneous populations. Studying this stochastic behavior could link molecular mechanisms to the aging process that determines life span. Therefore, C. elegans appears to be involved in physiological aspects that consistently respond to multiple interventions. The existence of invariant dynamics of organism aging in genetic and environmental contexts provides the basis for new quantitative frameworks to assess how and to what extent specific molecular processes contribute to the aspects of aging that determine lifespan. Others are Nutraceuticals, Telomerase, Calorie restriction, Thymus rejuvenating, and effects of some drugs as anti-aging.